{"id":1068267,"date":"2022-06-09T01:55:17","date_gmt":"2022-06-09T05:55:17","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/cormedix-to-participate-at-the-jmp-securities-life-sciences-conference\/"},"modified":"2024-08-18T11:45:08","modified_gmt":"2024-08-18T15:45:08","slug":"cormedix-to-participate-at-the-jmp-securities-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cormedix-to-participate-at-the-jmp-securities-life-sciences-conference.php","title":{"rendered":"CorMedix to Participate at the JMP Securities Life Sciences Conference"},"content":{"rendered":"<p><![CDATA[BERKELEY HEIGHTS, N.J., June  08, 2022  (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management will be participating in a fireside chat at the JMP Securities Life Sciences Conference being held in New York on June 15 \u2013 16, 2022.]]><\/p>\n<p>Go here to read the rest:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/08\/2458730\/0\/en\/CorMedix-to-Participate-at-the-JMP-Securities-Life-Sciences-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"CorMedix to Participate at the JMP Securities Life Sciences Conference\">CorMedix to Participate at the JMP Securities Life Sciences Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Go here to read the rest: CorMedix to Participate at the JMP Securities Life Sciences Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cormedix-to-participate-at-the-jmp-securities-life-sciences-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068267","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068267"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068267"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068267\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}